Advertisement

Topics

Boehringer Ingelheim's sales growth in 2018 hit by increasing price pressure on Spiriva https://www.firstwordpharma.com/node/1635651 

06:54 EDT 17 Apr 2019 | FirstWord Pharma

Boehringer Ingelheim's sales growth in 2018 hit by increasing price pressure on Spiriva https://www.firstwordpharma.com/node/1635651 

Original Article: Boehringer Ingelheim's sales growth in 2018 hit by increasing price pressure on Spiriva https://www.firstwordpharma.com/node/1635651 

NEXT ARTICLE

More From BioPortfolio on "Boehringer Ingelheim's sales growth in 2018 hit by increasing price pressure on Spiriva https://www.firstwordpharma.com/node/1635651 "

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...